A. Jeffrey Radov, Director at BioRestorative Therapies, Inc. (BRTX), bought 6,000 shares at $0.26 ($2K) on 2019-08-23, disclosed to the SEC on 2019-08-27.
Open-market purchase of $2k BRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.26 | 3,000 | $780 | 51.0% |
| 2 | $0.25 | 3,000 | $750 | 49.0% |
| Total | $0.26 avg | 6,000 | $2K | 100% |